Document is current
Any future updates will be listed below
-
Authors
Jebsen, Nina Louise https://orcid.org/0000-0003-3776-6774
Apelseth, Torunn Oveland
Haugland, Hans Kristian
Rekdal, Øystein
Patel, Hamina
Gjertsen, Bjørn Tore
Jøssang, Dag Eirik
-
Funding
Funding for this research was provided by:
University of Bergen (Post doc)
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 16 April 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: Ethics approval for the phase I study was obtained from the Regional Committee of Medical Research Ethics, South-Eastern-Norway (no. 2013/1650) (Rek Sør Øst D). Written consent was provided by the patient prior to inclusion in the phase I study.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: HP and ØR are employees of Lytix Biopharma. All of the other coauthors and the first author declare that they have no competing personal or political interests, commercial associations, or financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
